溶瘤病毒：一类新型免疫治疗药物。
Oncolytic viruses: a new class of immunotherapy drugs.
作者信息
Kaufman Howard L, Kohlhapp Frederick J, Zloza Andrew
出版信息
Nat Rev Drug Discov. 2016 Aug 30;15(9):660. doi: 10.1038/nrd.2016.178.
Abstract
This corrects the article DOI: 10.1038/nrd4663.
摘要
这修正了文章的数字对象标识符（DOI）：10.1038/nrd4663。
相似文献
1
Oncolytic viruses: a new class of immunotherapy drugs.溶瘤病毒：一类新型免疫治疗药物。
Nat Rev Drug Discov. 2016 Aug 30;15(9):660. doi: 10.1038/nrd.2016.178.
2
Fusogenic Viruses in Oncolytic Immunotherapy.溶瘤免疫疗法中的融合病毒
Cancers (Basel). 2018 Jun 26;10(7):216. doi: 10.3390/cancers10070216.
3
Harnessing the Power of Onco-Immunotherapy with Checkpoint Inhibitors.利用检查点抑制剂的肿瘤免疫疗法的力量。
Viruses. 2015 Nov 13;7(11):5889-901. doi: 10.3390/v7112914.
4
From virotherapy to oncolytic immunotherapy: where are we now?从病毒疗法到溶瘤免疫疗法：我们现在在哪里？
Curr Opin Virol. 2015 Aug;13:93-100. doi: 10.1016/j.coviro.2015.06.005. Epub 2015 Jun 26.
5
Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer.溶瘤免疫疗法：释放病毒靶向治疗癌症的潜力。
Cancer Immunol Immunother. 2017 Oct;66(10):1249-1264. doi: 10.1007/s00262-017-2025-8. Epub 2017 Jul 15.
6
OvirusTdb: A database of oncolytic viruses for the advancement of therapeutics in cancer.肿瘤溶瘤病毒数据库：一个用于癌症治疗推进的溶瘤病毒数据库。
Virology. 2020 Sep;548:109-116. doi: 10.1016/j.virol.2020.05.016. Epub 2020 Jun 9.
7
Integrating oncolytic viruses in combination cancer immunotherapy.将溶瘤病毒整合到联合癌症免疫疗法中。
Nat Rev Immunol. 2018 Aug;18(8):498-513. doi: 10.1038/s41577-018-0014-6.
8
Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and Immunocytokines.工程化新城疫病毒作为免疫检查点抑制剂和免疫细胞因子瘤内递送的溶瘤载体。
J Virol. 2020 Jan 17;94(3). doi: 10.1128/JVI.01677-19.
9
Corrigendum: Oncolytic Adenovirus-A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC.勘误：溶瘤腺病毒-A新星用于肝癌的基因靶向溶瘤病毒治疗。
Front Oncol. 2020 May 5;10:701. doi: 10.3389/fonc.2020.00701. eCollection 2020.
10
Unleashing the therapeutic potential of oncolytic viruses.释放溶瘤病毒的治疗潜力。
J Clin Invest. 2018 Apr 2;128(4):1258-1260. doi: 10.1172/JCI120303. Epub 2018 Mar 5.
引用本文的文献
1
Comparative safety and efficacy of oncolytic virotherapy for the treatment of individuals with malignancies: a systematic review, meta-analysis, and Bayesian network meta-analysis.溶瘤病毒疗法治疗恶性肿瘤患者的比较安全性和疗效：一项系统评价、荟萃分析和贝叶斯网络荟萃分析
EClinicalMedicine. 2025 Jul 19;86:103362. doi: 10.1016/j.eclinm.2025.103362. eCollection 2025 Aug.
2
Advances in Gene Therapy with Oncolytic Viruses and CAR-T Cells and Therapy-Related Groups.溶瘤病毒和嵌合抗原受体T细胞基因治疗进展及治疗相关分组
Curr Issues Mol Biol. 2025 Apr 10;47(4):268. doi: 10.3390/cimb47040268.
3
Efficacy of oncolytic virus in the treatment of intermediate-to-advanced solid tumors: a systematic review and meta-analysis.溶瘤病毒治疗中晚期实体瘤的疗效：一项系统评价和荟萃分析。
J Virol. 2025 Jul 22;99(7):e0064025. doi: 10.1128/jvi.00640-25. Epub 2025 Jun 20.
4
Extracellular vesicles as missiles for enhanced anti-tumor efficacy of oncolytic viruses: from disseminating oncolysis and anti-tumor immunity to targeted delivery.细胞外囊泡作为增强溶瘤病毒抗肿瘤疗效的“导弹”：从传播溶瘤作用和抗肿瘤免疫到靶向递送
Cell Commun Signal. 2025 Jun 11;23(1):276. doi: 10.1186/s12964-025-02283-z.
5
Endocrine cancer organoids in basic and translational medical research.基础与转化医学研究中的内分泌癌类器官
Sci China Life Sci. 2025 Jun 5. doi: 10.1007/s11427-024-2888-8.
6
Novel oncolytic vaccinia virus armed with interleukin-27 is a potential therapeutic agent for the treatment of murine pancreatic cancer.携带白细胞介素-27的新型溶瘤痘苗病毒是治疗小鼠胰腺癌的一种潜在治疗剂。
J Immunother Cancer. 2025 May 11;13(5):e010341. doi: 10.1136/jitc-2024-010341.
7
Precision oncolytic viral therapy in colorectal cancer: Genetic targeting and immune modulation for personalized treatment (Review).结直肠癌的精准溶瘤病毒疗法：用于个性化治疗的基因靶向和免疫调节（综述）
Int J Mol Med. 2025 Jul;56(1). doi: 10.3892/ijmm.2025.5545. Epub 2025 May 9.
8
Enhancing pancreatic cancer treatment: the role of H101 oncolytic virus in irreversible electroporation.增强胰腺癌治疗效果：H101溶瘤病毒在不可逆电穿孔中的作用
Front Immunol. 2025 Mar 18;16:1546242. doi: 10.3389/fimmu.2025.1546242. eCollection 2025.
9
Viral expression of NE/PPE enhances anti-colorectal cancer efficacy of oncolytic adenovirus by promoting TAM M1 polarization to reverse insufficient effector memory/effector CD8 T cell infiltration.神经内分泌蛋白/富含脯氨酸蛋白的病毒表达通过促进肿瘤相关巨噬细胞的M1极化，以逆转效应记忆/效应性CD8 T细胞浸润不足，从而增强溶瘤腺病毒的抗结直肠癌疗效。
J Exp Clin Cancer Res. 2025 Mar 14;44(1):97. doi: 10.1186/s13046-025-03358-y.
10
The Potential of Oncolytic Virotherapy in the Treatment of Head and Neck Cancer: A Comprehensive Review.溶瘤病毒疗法在头颈癌治疗中的潜力：综述
Int J Mol Sci. 2024 Dec 3;25(23):12990. doi: 10.3390/ijms252312990.
本文引用的文献
1
Oncolytic viruses: a new class of immunotherapy drugs.溶瘤病毒：一类新型免疫治疗药物。
Nat Rev Drug Discov. 2015 Sep;14(9):642-62. doi: 10.1038/nrd4663.
Zotero 插件